Fulminant hepatitis A: Disappearing, but not soon enough
โ Scribed by Raymond S. Koff
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 82 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Early identification of those patients with fulminant hepatic liver failure (FHF) who need a transplant greatly helps in their management. A number of prognostic criteria have recently been proposed, including arterial blood lactate and serum phosphate concentrations. To validate their use, we retro
The group at Pittsburgh have a vast experience with liver transplantation. They have shown that the procedure is effective and may be lifesaving. They now show that modem methods of immunosuppression can even allow liver transplantation across traditional ABO barriers. The price is high, but for som
onset of jaundice in a person without antecedent liver disease. 16 HBV hancer II-C promoter; ORF, open reading frame; Cys, cysteine.
largely unknown what kind of molecules and what kind of Concanavalin A (Con A) induces T-cell-mediated heregulation are critically involved in the hepatic injury. It has patic injury in vivo, although Con A-stimulated lymphobecome generally accepted that activated T lymphocytes are cytes are not cyt
## Objective: Hepatitis c virus (hcv) infection is associated with type ii cryoglobulinemia. hcv is specifically concentrated in type ii cryoglobulins and has been implicated in the cutaneous vasculitis associated with the disease. in contrast to hcv, a role for hepatitis g virus (hgv) in type ii c